Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty

Ophthalmic Surgery and Lasers

Volumn 27, Issue 8, 1996, Pages 657-660

  Threlkeld, Anisa B ^a   Assalian, Alfred A ^a   Allingham, R Rand ^a   Shields, M Bruce ^a,b  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE;

ARGON LASER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG FORMULATION; EYELID RETRACTION; HUMAN; HUMAN TISSUE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE ABNORMALITY; MYDRIASIS; PRIORITY JOURNAL; TRABECULOPLASTY;

ADMINISTRATION, TOPICAL; ADRENERGIC ALPHA-AGONISTS; CLONIDINE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LASER SURGERY; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TRABECULECTOMY;

EID: 0029775810     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Abrams DA, Robin AL, Pollack IP, deFaller JM, DeSantis L. The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers. Arch Ophthalmol. 1987;105:1205-1207.
2. Jampel HD, Robin AL, Quigley HA, Pollack IP. Apraclonidine: a one-week dose-response study. Arch Ophthalmol. 1988;106:1069-1073.
3. Abrams DA, Robin AL, Crandall AS, et al. A limited comparison of apraclonidine's dose response in subjects with normal or increased intraocular pressure. Am J Ophthalmol. 1989;108:230-237.
4. Blasini M, Shields MB. Apraclonidine hydrochloride as an adjunct to timolol maleate. J Glaucoma. 1992;1: 148-152.
5. Robin AL, Pollack IP, House B, Enger C. Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty. Arch Ophthalmol. 1987;105:646-650.
6. Brown RH, Stewart RH, Lynch MG, et al. ALO 2145 reduces the intraocular pressure elevation after anterior segment laser surgery. Ophthalmology. 1988;95:378-383.
7. Robin AL. The role of apraclonidine hydrochloride in laser therapy for glaucoma. Trans Am Ophthalmol Soc. 1989;87:729-761.
8. Krupin T, Stank T, Feitl ME. Apraclonidine pretreatment decreases the acute intraocular pressure rise after laser trabeculoplasty or iridotomy. J Glaucoma. 1992;1: 79-86.
9. Holmwood PC, Chase RD, Krupin T, et al. Apraclonidine and argon laser trabeculoplasty. Am J Ophthalmol. 1992;114:19-22.
10. Hoskins HD Jr, Hetherington J Jr, Minckler DS, et al. Complications of laser trabeculoplasty. Ophthalmology. 1983;90:796-799.
11. Weinreb RN, Ruderman J, Juster R, Zweig JR. Immediate intraocular pressure response to argon laser trabeculoplasty. Am J Ophthalmol. 1983;95:279-286.
12. Wilkerson M, Lewis RA, Shields MB. Follicular conjunctivitis associated with apraclonidine. Am J Ophthalmol. 1991;111:105-106.
13. Robin AL. Short-term effects of unilateral 1% apraclonidine therapy. Arch Ophthalmol. 1988;106:912-915.